Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
affiliated, affirmative, agent, allogenic, beneficiary, bloodstream, bone, buy, buying, capped, certainty, clarity, classification, CMO, coupled, Department, deteriorate, dispute, donut, eighteen, enjoined, excise, explaining, exploratory, forecasted, forfeited, free, fundraising, grantee, harder, hole, improperly, injectable, Innovation, internet, IRA, IRB, landscape, leave, led, levied, load, LPC, marrow, mobilization, orderly, outpace, paper, penalize, penny, pledge, precedent, preparatory, prophylactic, recognition, recoverability, reset, resigned, retention, revocation, revolutionize, SAR, secondary, settle, settled, settlement, short, show, smooth, speculative, stability, substance, Subtopic, suggest, thrid, Treasurer, Trust, twelve, unemployment, unitary, UPC, widespread
Removed:
abstract, accelerate, adjustment, administering, advancement, advisory, amplified, announcing, anticipation, applied, armed, art, assist, assume, attendance, begun, breast, Bruton, BTKi, calendar, carcinoma, ccRCC, clarify, clear, confirmed, conflict, constituting, constraint, construct, contact, continuity, contracting, count, created, CRO, decided, declaration, deducting, deepened, defer, desire, discovered, disorder, disrupted, distancing, diverted, Dr, drop, easing, EC, efficiency, EGC, emerging, enduring, enhancing, entrance, entry, essential, evolve, expanded, experiencing, explore, extinguished, facilitate, FASB, feature, FedEx, fill, finalized, fit, freestanding, furniture, gained, gene, genetic, goal, golden, head, Hedging, heightening, herd, holding, home, hybrid, idea, immunity, immunocompromised, immunodeficient, inconclusive, indirect, ineligible, inherited, inhibitor, initiated, interact, intrinsic, inventor, investigated, investigating, irrevocably, issuer, Jumpstart, kinase, leased, length, lifted, lowest, magnitude, Mayo, measuring, metabolic, minimal, Molecular, nonbinding, occupancy, opened, opt, optimal, optimize, optional, ordered, original, outbreak, outsourced, parachute, parte, Pathology, persist, phased, phenomenon, physical, postal, practical, practically, predicted, predominantly, preserving, principle, prioritization, prioritizing, productivity, projection, proven, quarantine, question, quoted, ratably, recession, recommended, redeemable, reducing, reexamination, refinancing, rejected, release, remote, renal, reopened, resale, residence, resurgence, returned, revised, RNA, roll, routine, Russia, satisfactory, scheduled, SCN, screening, serving, shorten, social, society, spread, stay, studied, studying, supplement, susceptibility, temporary, terminating, thirty, transform, transit, transitioned, travel, Treasury, tyrosine, unallocated, underway, undisclosed, vaccinated, vaccination, virtual, virtually, visit, water, weather, withdrawing, working, worsen
Filing tables
Filing exhibits
Related press release
Associated XFOR transcripts
XFOR similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Paula Ragan, Ph.D., Chief Executive Officer of X4 Pharmaceuticals, Inc. (the “Company”), and Adam S. Mostafa, Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:
1.The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, to which this Certification is attached as Exhibit 32.1 (the “Quarterly Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
2.The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
In Witness Whereof, the undersigned have set their hands hereto as of the 4th day of May, 2023.
/s/ Paula Ragan, Ph.D. /s/ Adam S. Mostafa
Paula Ragan, Ph.D. Adam S. Mostafa
Chief Executive Officer Chief Financial Officer
(Principal Executive Officer) (Principal Financial Officer and Principal Accounting Officer)